Medicare Enrolled
Dr. David Laub, M.D.
Dermatology · Mill Valley, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Laub from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Laub?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Laub
Dr. David Laub is a dermatology specialist in Mill Valley, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Laub performed 8,562 Medicare services across 3,979 unique beneficiaries.
Between the years covered by Open Payments, Dr. Laub received a total of $33,079 from 27 pharmaceutical and/or device companies across 139 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Laub is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 11% volume in CA
$33,079 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,562
Medicare services
Top 11% in CA for dermatology
3,979
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~476 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
2,667 | $6 | $10 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
941 | $40 | $106 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
851 | $70 | $111 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
792 | $108 | $179 |
| UV therapy with tar or petroleum jelly A treatment using ultraviolet radiation combined with the application of tar or petroleum jelly to the skin. |
720 | $119 | $152 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
609 | $45 | $85 |
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
586 | $68 | $120 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
384 | $68 | $160 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
365 | $159 | $239 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
89 | $82 | $165 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
74 | $1 | $10 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
70 | $46 | $100 |
| Simple drainage of skin abscess A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing. |
55 | $120 | $186 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
54 | $36 | $86 |
| Complex or multiple skin abscess drainage A procedure to drain one or more skin abscesses that are complex in nature. This involves opening and cleaning the infected pockets under the skin. |
51 | $191 | $318 |
| Destruction of cancerous skin growth on face, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 0.6 and 1.0 centimeters in diameter. |
32 | $164 | $279 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
31 | $153 | $278 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
26 | $56 | $120 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
24 | $107 | $165 |
| Complicated wound repair, 2.6-7.5 cm A complex surgical procedure to close a wound measuring between 2.6 and 7.5 centimeters on areas such as the face, neck, hands, or feet. |
23 | $467 | $748 |
| Complicated wound repair, scalp/arms/legs, 2.6-7.5 cm A complex surgical procedure to close a wound on the scalp, arms, or legs that measures between 2.6 and 7.5 centimeters in length. |
21 | $425 | $677 |
| Surgical removal of facial skin cancer, 1.1-2.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the removed tissue is between 1.1 and 2.0 centimeters. |
20 | $139 | $424 |
| Complicated wound repair of trunk, 2.6-7.5 cm A surgical procedure to close a complex wound on the trunk that measures between 2.6 and 7.5 centimeters in length. |
17 | $397 | $632 |
| Destruction of cancerous skin growth on face, 1.1-2.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 1.1 and 2.0 centimeters in diameter. |
17 | $190 | $320 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
15 | $155 | $390 |
| Destruction of cancer skin growth, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters. |
15 | $129 | $234 |
| Destruction of cancerous skin growth, 2.1-3.0 cm This procedure involves the removal or destruction of a cancerous skin lesion measuring between 2.1 and 3.0 centimeters located on the trunk, arms, or legs. |
13 | $185 | $302 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$33,079
Total received (2018-2024)
Avg $4,726/year across 7 years
Top 8% in CA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
139
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$18,071 (54.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$11,477 (34.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,531 (10.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,365
2023
$680
2022
$10,454
2021
$48
2020
$5,658
2019
$14,247
2018
$627
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Galderma Laboratories, L.P.
$582
PFIZER INC.
$303
ABBVIE INC.
$171
LEO Pharma Inc.
$110
Solta Medical, a division of Bausch Health US, LLC
$98
Edap Technomed Inc
$75
Lilly USA, LLC
$25
Top 3 companies account for 77.4% of 2024 payments
All-time payments by company (2018-2024) ›
Galderma Laboratories, L.P.
$20,179
DERMIRA, INC.
$5,787
Allergan, Inc.
$4,442
Solta Medical, a division of Bausch Health US, LLC
$409
PFIZER INC.
$352
Allergan Inc.
$278
ABBVIE INC.
$171
Janssen Biotech, Inc.
$140
LEO Pharma Inc.
$138
Amgen Inc.
$131
Merz North America, Inc.
$125
Sun Pharmaceutical Industries Inc.
$125
E.R. Squibb & Sons, L.L.C.
$125
AbbVie, Inc.
$114
Endo Pharmaceuticals Inc.
$84
Edap Technomed Inc
$75
Janssen Scientific Affairs, LLC
$70
Arcutis Biotherapeutics, Inc.
$65
Celgene Corporation
$55
Novartis Pharmaceuticals Corporation
$50
Ortho Dermatologics, a division of Bausch Health US, LLC
$44
Lilly USA, LLC
$25
Aclaris Therapeutics, Inc.
$25
TOLMAR Pharmaceuticals, Inc.
$22
MERZ NORTH AMERICA, INC.
$21
STRATA Skin Sciences, Inc.
$16
Almirall LLC
$12
Top 3 companies account for 91.9% of all-time payments
Associated products mentioned in payments ›
ADBRY · AVEED · BOTOX · BOTOX COSMETIC · CIBINQO · COSENTYX · DUOBRII · DYSPORT · Dermatological Psoriasis and Vitiligo Treatment · ELIGARD · ENSTILAR · EPIDUO FORTE · Fraxel · Humira · ILUMYA · KYBELLA · LITFULO · Otezla · QBREXZA · RHOFADE · Sotyktu · TALTZ · TREMFYA · Tremfya · Veltin · XEOMIN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (55%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 8% for dermatology in CA.
Geographic Context
Dermatologists within 10 mi
196
Per 100K population
75.7
County median income
$142,785
Nearest hospital
MARINHEALTH MEDICAL CENTER
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Laub is a clinical cardiology specialist, with above-average Medicare volume (top 11% in CA), with consulting-driven industry engagement in the top 8% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Laub experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Laub performed 2,667 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Laub receive payments from pharmaceutical companies?
Yes. Dr. Laub received a total of $33,079 from 27 companies across 139 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Laub's costs compare to other dermatologists in Mill Valley?
Dr. Laub's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Laub) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Mill Valley
Browse dermatologists in Mill Valley ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in CA
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in CA
Which CA dermatologists receive the most from drug and device companies.
By company
Galderma Laboratories, L.P. Payments to Doctors
See all physicians who received payments from Galderma Laboratories, L.P.
By company
DERMIRA, INC. Payments to Doctors
See all physicians who received payments from DERMIRA, INC.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology